Aktis Oncology, Inc. AKTS
CIK 0002035832
Form 4 transactions dated Sep 1, 2023 to Sep 23, 2026, as reported to the SEC.
Insider purchases & sales
- Purchased
- $114.31M
- Sold
- $2.97M
Sep 1, 2023 – Jul 21, 2026
Available records · partial months are marked ·
| Date | Insider | Activity | Trade value (USD) | % of prior holding | |
|---|---|---|---|---|---|
| 2026-07-20 | Herrmann Ken Director | Sale | $119.27K 4,856 shares sold | 100.00% sold Direct holding | ▾ |
| 2026-07-17 | Herrmann Ken Director | Sale | $77.26K 3,065 shares sold | 100.00% sold Direct holding | ▾ |
| 2026-07-08 | Ron-Bigger Shulamit Chief Operating Officer | Sale | $1.39M 50,000 shares sold | 100.00% sold Direct holding | ▾ |
| 2026-07-08 | Czibere Akos Chief Medical Officer | Sale | $1.39M 50,000 shares sold | 100.00% sold Direct holding | ▾ |
| 2026-01-12 | Foley Todd Director · 10% owner | Purchase | $4.19M 232,870 shares bought | 5.82% added Indirect holding | ▾ |
| 2026-01-12 | EVNIN LUKE · MPM ONCOLOGY INNOVATIONS FUND LP · MPM BIOVENTURES 2018 (B), L.P. · MPM BIOVENTURES 2018, L.P. · MPM ASSET MANAGEMENT INVESTORS BV2018 LLC · MPM BioVentures 2018 GP LLC · MPM BioVentures 2018 LLC · MPM Oncology Innovations Fund GP LLC 10% owner | Purchase | $20.03M 1,112,777 shares bought | Unavailable Indirect holding | ▾ |
| 2026-01-12 | GADICKE ANSBERT · MPM ASSET MANAGEMENT LLC · Oncology Impact Private Investment Fund 2, L.P. 10% owner | Purchase | $20.03M 1,112,777 shares bought | Unavailable Indirect holding | ▾ |
| 2026-01-12 | Vida Ventures II, LLC · VIDA VENTURES II-A, LLC 10% owner | Purchase | $15.03M 835,000 shares bought | Unavailable Indirect holding | ▾ |
| 2026-01-12 | Kim Helen Susan Director · 10% owner | Purchase | $15.03M 835,000 shares bought | Unavailable Indirect holding | ▾ |
| 2026-01-12 | NODELMAN OLEG · EcoR1 Capital, LLC Director | Purchase | $40.00M 2,222,222 shares bought | Unavailable Indirect holding | ▾ |
Showing 10 / 10 record groups in 2026. The complete set is available through the API.
Follow the people behind the trades.
Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.
- Download CSV
- Earlier filings
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 10 of 10 purchase / sale groups and 30 of 43 other groups; the totals and the monthly series cover the whole window.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
list_insider_transactions
{"ticker":"AKTS","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.